Clinical Trials for Telangiectasia, Hereditary Hemorrhagic

Find clinical trials for telangiectasia, hereditary hemorrhagic. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients

NCT ID: NCT04976036

This clinical trial is studying the effect of a medication called nintedanib on reducing frequent nosebleeds, known as epistaxis, in patients with a condition called hereditary hemorrhagic telangie...

Recruiting

Phase: PHASE2 Type: interventional Locations: Lausanne, Vaud, Switzerland

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families

NCT ID: NCT00230620

This clinical trial is studying hereditary hemorrhagic telangiectasia (HHT), a condition that affects blood vessels and can cause bleeding. The researchers aim to understand the specific genes invo...

Recruiting

Type: observational Locations: London, , United Kingdom

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

NCT ID: NCT00230685

This clinical trial is studying a condition called Hereditary Haemorrhagic Telangiectasia (HHT), which can cause abnormal blood vessel growth and bleeding. The study is being conducted at Hammersmi...

Recruiting

Type: observational Locations: London, , United Kingdom

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions